Cooper Companies Inc

COO ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $2.14B $1.97B $1.80B $1.72B $1.59B $1.44B $1.30B $1.16B
CooperVision $1.66B $1.53B $1.48B $1.40B $1.29B $1.16B $1.03B $918.0M
CooperSurgical $476.1M $437.3M $322.6M $318.5M $304.5M $282.8M $264.4M $240.2M
Cost of Revenue $773.2M $793.7M $726.8M $626.2M $560.9M $521.1M $526.0M $481.8M
Gross Profit $1.37B $1.17B $1.07B $1.09B $1.03B $924.0M $804.8M $676.7M
Gross Margin 63.8% 59.7% 59.5% 63.4% 64.4% 64.1% 62.0% 58.4%
Operating Expenses
Research & Development $69.2M $65.4M $69.6M $66.3M $58.8M $51.7M $43.6M $35.3M
SG&A Expense $799.1M $722.8M $712.5M $683.1M $610.7M $564.9M $513.1M $433.1M
Operating Income $429.1M $324.1M $236.7M $306.5M $305.9M $283.4M $227.6M $189.9M
Operating Margin 20.1% 16.5% 13.2% 17.8% 19.2% 19.7% 17.5% 16.4%
Interest Expense $33.4M $26.2M $18.1M $8.0M $9.2M $11.8M $17.3M $36.7M
Pretax Income $394.0M $295.6M $215.5M $296.5M $312.3M $275.5M $192.8M $124.4M
Income Tax Expense $21.1M $20.7M $10.4M $24.7M $15.4M $26.8M $17.3M $11.6M
Net Income $372.9M $273.9M $203.5M $269.9M $296.2M $248.3M $175.4M $112.8M
Net Margin 17.4% 13.9% 11.3% 15.7% 18.6% 17.2% 13.5% 9.7%
EPS (Basic) $1.91 $1.41 $1.05 $1.40 $1.52 $1.30 $0.94 $0.62
EPS (Diluted) $1.88 $1.40 $1.04 $1.38 $1.49 $1.26 $0.91 $0.61
Shares Outstanding (Basic) 195.6M 194.0M 194.0M 192.2M 194.5M 191.7M 187.6M 182.1M
Shares Outstanding (Diluted) 198.4M 196.0M 196.8M 195.8M 198.7M 196.6M 193.2M 186.0M
Dividends Per Share $0.01 $0.01 $0.01 $0.01 $0.01 $0.01
← Newer Page 2 of 3 Older →